Search

Search Constraints

You searched for: Author/Creator Gururangan, Sridharan

Search Results

1. A phase I trial of the CDK 4/6 inhibitor palbociclib in pediatric patients with progressive brain tumors: A Pediatric Brain Tumor Consortium study (PBTC‐042). Issue 4 (6th January 2021)

2. A phase II trial of selumetinib in children with recurrent optic pathway and hypothalamic low-grade glioma without NF1: a Pediatric Brain Tumor Consortium study. Issue 10 (25th February 2021)

3. Accuracy of central neuro-imaging review of DIPG compared with histopathology in the International DIPG Registry. Issue 5 (20th October 2021)

5. Bevacizumab (BVZ)‐associated toxicities in children with recurrent central nervous system tumors treated with BVZ and irinotecan (CPT‐11). Issue 23 (19th September 2013)

6. Bevacizumab (BVZ)‐associated toxicities in children with recurrent central nervous system tumors treated with BVZ and irinotecan (CPT‐11): A Pediatric Brain Tumor Consortium Study (PBTC‐022). Issue 23 (19th September 2013)

7. Bevacizumab dosing strategy in paediatric cancer patients based on population pharmacokinetic analysis with external validation. (10th December 2015)

8. Characteristics of patients ≥10 years of age with diffuse intrinsic pontine glioma: a report from the International DIPG/DMG Registry. Issue 1 (11th June 2021)

10. Clinical Outcomes and Patient-Matched Molecular Composition of Relapsed Medulloblastoma. Issue 7 (1st March 2021)